Variant report
Variant | nsv511354 |
---|---|
Chromosome Location | chr6:74828682-74851053 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-CD109-8 | chr6:74835887-74836024 | ucscGeneNc_uc003phr_2 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs188207272 | chr6:74835890-74835891 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs528024878 | chr6:74835896-74835897 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs180790447 | chr6:74835923-74835924 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs570760816 | chr6:74835956-74835957 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs114475926 | chr6:74836005-74836006 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs572068585 | chr6:74837208-74837209 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs34533540 | chr6:74837221-74837222 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs545413879 | chr6:74837244-74837245 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs35102674 | chr6:74837255-74837256 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs369426638 | chr6:74837257-74837258 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs113312357 | chr6:74837269-74837270 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs543696642 | chr6:74837297-74837298 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs147649436 | chr6:74837327-74837328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs536595349 | chr6:74837330-74837331 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs75936320 | chr6:74837347-74837348 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs1934021 | chr6:74837385-74837386 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs149082202 | chr6:74837386-74837387 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs183355212 | chr6:74837435-74837436 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs569542207 | chr6:74837442-74837443 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs551827062 | chr6:74837506-74837507 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs187045052 | chr6:74837539-74837540 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs538184989 | chr6:74837562-74837563 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs558671553 | chr6:74837564-74837565 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs191535476 | chr6:74837579-74837580 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs142188977 | chr6:74837594-74837595 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs116799719 | chr6:74837602-74837603 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs182284291 | chr6:74837611-74837612 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs34623072 | chr6:74837635-74837636 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs571833452 | chr6:74837714-74837715 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs530437225 | chr6:74837748-74837749 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs557369327 | chr6:74837777-74837778 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs575627831 | chr6:74837845-74837846 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs576902960 | chr6:74837864-74837865 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs188047797 | chr6:74837905-74837906 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs151273035 | chr6:74837978-74837979 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs544821641 | chr6:74838005-74838006 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
37 | rs541287086 | chr6:74838006-74838007 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
38 | rs559875628 | chr6:74838015-74838016 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
39 | rs533501628 | chr6:74838028-74838029 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
40 | rs551896788 | chr6:74838075-74838076 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
41 | rs193261704 | chr6:74838081-74838082 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
42 | rs530932246 | chr6:74838087-74838088 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
43 | rs549321372 | chr6:74838128-74838129 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
44 | rs140498938 | chr6:74838137-74838138 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
45 | rs145616063 | chr6:74838165-74838166 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
46 | rs185370876 | chr6:74838179-74838180 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
47 | rs565527354 | chr6:74838197-74838198 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
48 | rs12198091 | chr6:74838268-74838269 | Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs138226847 | chr6:74838277-74838278 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
50 | rs575689659 | chr6:74838278-74838279 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Ovarian cancer | 17437010 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioma | 17123091 | CNVD |
Mental retardation | 17124404 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
Breast cancer | 17133270 | CNVD |
Leukemia | 18688285 | CNVD |
Prostate cancer | 19242612 | CNVD |
Developmental delay | 21147756 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:74837200-74837400 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
2 | chr6:74837400-74838200 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
3 | chr6:74838000-74838800 | Bivalent Enhancer | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
4 | chr6:74838200-74838600 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
5 | chr6:74839200-74840000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr6:74843000-74843200 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
7 | chr6:74846800-74848000 | Enhancers | HUVEC | blood vessel |
8 | chr6:74847400-74848200 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
9 | chr6:74847600-74848000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
10 | chr6:74847600-74848000 | Enhancers | H9 Cell Line | embryonic stem cell |
11 | chr6:74847600-74848000 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
12 | chr6:74847600-74848000 | Enhancers | Osteobl | bone |
13 | chr6:74847600-74848200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
14 | chr6:74847600-74848200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
15 | chr6:74847600-74848200 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
16 | chr6:74847600-74848200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
17 | chr6:74847600-74848200 | Enhancers | HMEC | breast |
18 | chr6:74847600-74848200 | Enhancers | NHDF-Ad | bronchial |
19 | chr6:74847600-74848200 | Enhancers | NHEK | skin |
20 | chr6:74847800-74848200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
21 | chr6:74847800-74848200 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
22 | chr6:74847800-74848200 | Enhancers | Ovary | ovary |
23 | chr6:74848000-74848400 | Flanking Active TSS | HUVEC | blood vessel |
24 | chr6:74848400-74849400 | Enhancers | HUVEC | blood vessel |